Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia.

Kiss T, Hoffmann WE, Hajós M.

Int J Neuropsychopharmacol. 2011 Feb;14(1):29-42. doi: 10.1017/S1461145710000271. Epub 2010 Mar 25.

PMID:
20334724
2.

GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression.

Yoon JH, Maddock RJ, Rokem A, Silver MA, Minzenberg MJ, Ragland JD, Carter CS.

J Neurosci. 2010 Mar 10;30(10):3777-81. doi: 10.1523/JNEUROSCI.6158-09.2010.

3.

Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia.

Duncan CE, Webster MJ, Rothmond DA, Bahn S, Elashoff M, Shannon Weickert C.

J Psychiatr Res. 2010 Jul;44(10):673-81. doi: 10.1016/j.jpsychires.2009.12.007. Epub 2010 Jan 25.

PMID:
20100621
4.

Abnormal neural oscillations and synchrony in schizophrenia.

Uhlhaas PJ, Singer W.

Nat Rev Neurosci. 2010 Feb;11(2):100-13. doi: 10.1038/nrn2774. Review.

PMID:
20087360
5.

1H-MRS at 4 tesla in minimally treated early schizophrenia.

Bustillo JR, Rowland LM, Mullins P, Jung R, Chen H, Qualls C, Hammond R, Brooks WM, Lauriello J.

Mol Psychiatry. 2010 Jun;15(6):629-36. doi: 10.1038/mp.2009.121. Epub 2009 Nov 17.

6.

Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation.

Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, Marangoni S, Turck CW, Dias-Neto E.

BMC Psychiatry. 2009 Apr 30;9:17. doi: 10.1186/1471-244X-9-17.

7.

The dopamine hypothesis of schizophrenia: version III--the final common pathway.

Howes OD, Kapur S.

Schizophr Bull. 2009 May;35(3):549-62. doi: 10.1093/schbul/sbp006. Epub 2009 Mar 26. Review.

8.

Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia.

Beasley CL, Dwork AJ, Rosoklija G, Mann JJ, Mancevski B, Jakovski Z, Davceva N, Tait AR, Straus SK, Honer WG.

Schizophr Res. 2009 Apr;109(1-3):159-66. doi: 10.1016/j.schres.2009.01.017. Epub 2009 Mar 9.

9.

Proton MRS in twin pairs discordant for schizophrenia.

Lutkenhoff ES, van Erp TG, Thomas MA, Therman S, Manninen M, Huttunen MO, Kaprio J, Lönnqvist J, O'Neill J, Cannon TD.

Mol Psychiatry. 2010 Mar;15(3):308-18. doi: 10.1038/mp.2008.87. Epub 2008 Jul 22.

PMID:
18645571
10.

Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex.

Del Arco A, Mora F.

Pharmacol Biochem Behav. 2008 Aug;90(2):226-35. doi: 10.1016/j.pbb.2008.04.011. Epub 2008 Apr 23. Review.

PMID:
18508116
11.

Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.

Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF.

Nat Neurosci. 2007 Mar;10(3):376-84. Epub 2007 Feb 4.

PMID:
17277774
12.

How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?

Kondziella D, Brenner E, Eyjolfsson EM, Sonnewald U.

Neurochem Int. 2007 Jan;50(2):291-301. Epub 2006 Nov 7. Review.

PMID:
17084946
13.

Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia.

Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Nicholson JK, Bahn S.

PLoS Med. 2006 Aug;3(8):e327.

14.
15.

Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.

Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T.

Psychiatry Clin Neurosci. 2006 Jun;60(3):365-72.

16.

Repeated injection of MK801: an animal model of schizophrenia?

Eyjolfsson EM, Brenner E, Kondziella D, Sonnewald U.

Neurochem Int. 2006 May-Jun;48(6-7):541-6. Epub 2006 Mar 3.

PMID:
16517016
17.

A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.

Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Raeder H, Giegling I, Genius J, McCarley RW, Möller HJ, Grunze H.

Biol Psychiatry. 2006 Apr 15;59(8):721-9. Epub 2006 Jan 19.

PMID:
16427029
18.

Glial-neuronal interactions are impaired in the schizophrenia model of repeated MK801 exposure.

Kondziella D, Brenner E, Eyjolfsson EM, Markinhuhta KR, Carlsson ML, Sonnewald U.

Neuropsychopharmacology. 2006 Sep;31(9):1880-7. Epub 2005 Dec 14.

19.
20.

Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801.

Brenner E, Kondziella D, Håberg A, Sonnewald U.

J Neurochem. 2005 Sep;94(6):1594-603. Epub 2005 Jul 25.

Supplemental Content

Support Center